Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Type B Immunisation”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Large-scale testing (Phase 3)Study completedNCT00169442
What this trial is testing

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Who this might be right for
Whole Cell PertussisDiphtheriaHepatitis B+2 more
GlaxoSmithKline 745
Large-scale testing (Phase 3)Study completedNCT01062477
What this trial is testing

DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 1,056
Testing effectiveness (Phase 2)Study completedNCT00871338
What this trial is testing

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 284
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Post-approval studies (Phase 4)Study completedNCT01491087
What this trial is testing

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 900
Large-scale testing (Phase 3)Study completedNCT01214889
What this trial is testing

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi 370
Not applicableStudy completedNCT06793826
What this trial is testing

Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

Who this might be right for
Hepatitis BHaemophilus Influenzae Type b Immunisation
Sanofi Pasteur, a Sanofi Company 713
Testing effectiveness (Phase 2)Study completedNCT01061541
What this trial is testing

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

Who this might be right for
Haemophilus Influenzae Type b
GlaxoSmithKline 192
Not applicableStudy completedNCT03870061
What this trial is testing

Evaluation of an Infant Immunization Encouragement Program in Nigeria

Who this might be right for
TuberculosisDiphtheriaTetanus+8 more
GiveWell 5,187
Large-scale testing (Phase 3)Study completedNCT06413121
What this trial is testing

Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Who this might be right for
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd. 1,557
Large-scale testing (Phase 3)Study completedNCT00332566
What this trial is testing

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Who this might be right for
Hepatitis BWhole Cell PertussisTetanus+2 more
GlaxoSmithKline 148
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Post-approval studies (Phase 4)UnknownNCT02179996
What this trial is testing

Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates

Who this might be right for
Hib Immunisation in Very Preterm-born InfantsPertussis Immunisation in Very Preterm-born Infants
Central Hospital, Nancy, France 160
Large-scale testing (Phase 3)Study completedNCT01251133
What this trial is testing

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 122
Large-scale testing (Phase 3)Study completedNCT00345579
What this trial is testing

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,432
Post-approval studies (Phase 4)Study completedNCT01357720
What this trial is testing

Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 400
Large-scale testing (Phase 3)Study completedNCT00169728
What this trial is testing

Vaccination of Children Following Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Haematopoietic Stem Cell Transplantation
Heinrich-Heine University, Duesseldorf 53
Large-scale testing (Phase 3)Study completedNCT00379977
What this trial is testing

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

Who this might be right for
TetanusHaemophilus Influenzae Type bAcellular Pertussis+1 more
GlaxoSmithKline 30
Next Page